Provided by Tiger Trade Technology Pte. Ltd.

ResMed

219.58
-0.3700-0.17%
Post-market: 219.580.00000.00%17:04 EDT
Volume:845.69K
Turnover:185.75M
Market Cap:31.67B
PE:21.05
High:221.25
Open:217.93
Low:215.80
Close:219.95
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:0.64
T/O Rate:0.59%
Dividend:2.40
Dividend Rate:1.09%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.81
PE(LYR):21.05

Loading ...

Movement Alert|ResMed Falls 8.41% in Pre-Market Trading, Earnings Beat Expectations but Revenue Growth Deceleration Sparks Concern

Market Focus
·
Aug 07

Resmed Inc. : RBC Raises Target Price to $244 from $234

THOMSON REUTERS
·
Aug 07

Resmed Inc. : Piper Sandler Cuts Target Price to $225 from $233

THOMSON REUTERS
·
Aug 07

Stock Track | ResMed Plunges 6.07% in 24-Hour Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Declines 6.15% Overnight, Earnings Beat but Revenue Growth Slowdown Sparks Concerns

Market Focus
·
Aug 07

Deferral of Conversions Between Australian and US Registers-RMD.N

Reuters
·
Aug 07

144 Report of Proposed Sale of Securities-RMD.N

Reuters
·
Aug 07

Resmed Q4 FY2026 Earnings: Revenue Rises as Safety Costs Weigh on GAAP Margins

TradingKey
·
Aug 07

ResMed Fiscal Q4 Non-GAAP Earnings, Revenue Up

MT Newswires Live
·
Aug 07

ResMed Raises Quarterly Dividend, Reports Higher 4Q Revenue, Profit

Dow Jones
·
Aug 07

ResMed Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

ResMed Posts Fiscal Q4 Non-GAAP EPS of $2.95, Revenue of $1.46 Billion

MT Newswires Live
·
Aug 07

Stock Track | ResMed Plunges 6.83% in After-Hours Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Falls 5.03% in After-Hours Trading, Earnings Beat but Growth Deceleration Raises Concerns

Market Focus
·
Aug 07

ResMed Q4 FY26 GAAP Diluted EPS Rises 2% to $2.64; Revenue Increases 9% to $1.46 Billion

Reuters
·
Aug 07

Resmed Q4 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 07

Resmed Q4 Adjusted EPS USD 2.95 Vs. IBES Estimate USD 2.89

Reuters
·
Aug 07

ResMed Q4 Adj. EPS $2.95 Beats $2.89 Estimate, Sales $1.464B Beat $1.459B Estimate

Benzinga Earnings
·
Aug 07

Resmed - Guides to Return over $1.85 Bln to Shareholders in Fy2027; Raises Qtrly Dividend 10% to $0.66

THOMSON REUTERS
·
Aug 07

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

THOMSON REUTERS
·
Aug 07